Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Acquisitions & Divestments (2016 - 2024)

Myriad Genetics (MYGN) has disclosed Change in Acquisitions & Divestments for 16 consecutive years, with $5.0 million as the latest value for Q3 2024.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 66.67% to $5.0 million in Q3 2024 year-over-year; TTM through Jun 2025 was $5.0 million, a 75.61% decrease, with the full-year FY2024 number at $9.0 million, down 91.44% from a year prior.
  • Change in Acquisitions & Divestments was $5.0 million for Q3 2024 at Myriad Genetics, up from $2.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $58.1 million in Q1 2023 to a low of $1.5 million in Q4 2023.
  • A 5-year average of $21.7 million and a median of $18.6 million in 2020 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 318.9% in 2020, then crashed 97.42% in 2024.
  • Myriad Genetics' Change in Acquisitions & Divestments stood at $35.9 million in 2020, then tumbled by 32.31% to $24.3 million in 2021, then surged by 67.08% to $40.6 million in 2022, then crashed by 96.31% to $1.5 million in 2023, then soared by 233.33% to $5.0 million in 2024.
  • Per Business Quant, the three most recent readings for MYGN's Change in Acquisitions & Divestments are $5.0 million (Q3 2024), $2.5 million (Q2 2024), and $1.5 million (Q1 2024).